Related Experiment Video
Updated: Sep 25, 2026
Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Pleotropic effects of genistein on MCF-7 breast cancer cells
Sreenivasa R Chinni1, Samir A Alhasan, Asha S Multani
1Department of Urology and Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Abstract:
Soy isoflavone, genistein has been shown to induce growth inhibition, cell cycle arrest and apoptosis in cultured cancer cell lines derived from head and neck, breast, lung, and prostate cancers and showed antitumor activity against tumors in multiple animal models. In the present study we show that genistein inhibits the growth of MCF-7 breast cancer cell line in a dose dependent manner. The genistein induced growth inhibition is accompanied by the reduction in the number of mitotic cells and overexpression of cyclin dependent kinase inhibitor p21WAF1 leading to cell cycle arrest. In addition, the telomeric area was significantly reduced in genistein treated MCF-7 cells. Analysis of multiple genes involving the apoptotic pathway reveals inhibition of Akt activity without affecting the steady state levels of Akt protein expression and the down regulation of proapoptotic gene BAD expression. From these results, we conclude that genistein-induced inhibition of cell division is partly mediated by decreased telomere length, reduced mitosis and inhibition of Akt activation, leading to induction of apoptosis.
Insights
Genistein, a soy isoflavone, inhibits breast cancer cell growth by reducing mitosis and telomere length. This leads to cell cycle arrest and apoptosis, offering potential therapeutic strategies.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- Soy isoflavone genistein exhibits anticancer properties against various cancer cell lines and animal models.
- Genistein has demonstrated potential in inhibiting cancer cell growth, cell cycle arrest, and apoptosis.
Purpose of the Study:
- To investigate the effects of genistein on the MCF-7 breast cancer cell line.
- To elucidate the molecular mechanisms underlying genistein-induced growth inhibition and apoptosis.
Main Methods:
- Cell culture of MCF-7 breast cancer cells.
- Dose-dependent treatment with genistein.
- Analysis of cell cycle, mitosis, telomere length, and apoptotic pathway gene expression.
- Western blot analysis for Akt protein and gene expression of p21WAF1 and BAD.
Main Results:
- Genistein inhibited MCF-7 cell growth in a dose-dependent manner.
- Genistein treatment led to reduced mitosis, cell cycle arrest via p21WAF1 overexpression, and decreased telomere length.
- Genistein inhibited Akt activity and downregulated the proapoptotic gene BAD.
Conclusions:
- Genistein-induced inhibition of cell division in breast cancer cells is mediated by reduced telomere length, decreased mitosis, and Akt pathway inhibition.
- These mechanisms contribute to the induction of apoptosis, highlighting genistein's potential as an anticancer agent.
